Global Pediatrics Partnering Deal Trends, Players and Financials 2012-2018

Dublin, March 15, 2018 (GLOBE NEWSWIRE) -- The "Global Pediatrics Partnering 2012-2018: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering.

Global Pediatrics Partnering 2012 to 2018 provides the full collection of Pediatrics disease deals signed between the world's pharmaceutical and biotechnology companies since 2012.

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Pediatrics disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Pediatrics deals.

The report presents financial deal terms values for Pediatrics deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

In addition, a comprehensive appendix is provided with each report of all Pediatrics partnering deals signed and announced since 2012. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Pediatrics partnering and dealmaking since 2012.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Pediatrics technologies and products.

Report scope

Global Pediatrics Partnering 2012 to 2018 includes:

• Trends in Pediatrics dealmaking in the biopharma industry since 2012
• Analysis of Pediatrics deal structure
• Access to headline, upfront, milestone and royalty data
• Access to hundreds of Pediatrics deal contract documents
• Comprehensive access to over 3500 Pediatrics deal records
• The leading Pediatrics deals by value since 2012
• Most active Pediatrics dealmakers since 2012

In Global Pediatrics Partnering 2012 to 2018, available deals and contracts are listed by:

• Headline value
• Upfront payment value
• Royalty rate value
• Stage of development at signing
• Deal component type
• Technology type
• Specific therapy indication
  

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Pediatrics dealmaking

2.1. Introduction
2.2. Pediatrics partnering over the years
2.3. Pediatrics partnering by deal type
2.4. Pediatrics partnering by industry sector
2.5. Pediatrics partnering by stage of development
2.6. Pediatrics partnering by technology type
2.7. Pediatrics partnering by therapeutic indication

Chapter 3 - Financial deal terms for Pediatrics partnering

3.1. Introduction
3.2. Disclosed financials terms for Pediatrics partnering
3.3. Pediatrics partnering headline values
3.4. Pediatrics deal upfront payments
3.5. Pediatrics deal milestone payments
3.6. Pediatrics royalty rates

Chapter 4 - Leading Pediatrics deals and dealmakers

4.1. Introduction
4.2. Most active in Pediatrics partnering
4.3. List of most active dealmakers in Pediatrics
4.4. Top Pediatrics deals by value

Chapter 5 - Pediatrics contract document directory

5.1. Introduction
5.2. Pediatrics partnering deals where contract document available

Chapter 6 - Pediatrics dealmaking by therapeutic target

6.1. Introduction
6.2. Deals by Pediatrics therapeutic target

Appendices

Appendix 1 - Directory of Pediatrics deals by company A-Z 2012 to 2018
Appendix 2 - Directory of Pediatrics deals by deal type 2012 to 2018
Appendix 3 - Directory of Pediatrics deals by stage of development 2012 to 2018
Appendix 4 - Directory of Pediatrics deals by technology type 2012 to 2018

For more information about this report visit https://www.researchandmarkets.com/research/h9wh6w/global_pediatrics?w=12

                    
                    
                    CONTACT: ResearchAndMarkets.com
                             Laura Wood, Senior Manager
                             press@researchandmarkets.com
                             For E.S.T Office Hours Call 1-917-300-0470
                             For U.S./CAN Toll Free Call 1-800-526-8630
                             For GMT Office Hours Call +353-1-416-8900
                             Related Topics: Pharmaceuticals, Pediatrics